We are live on
!
Find out more
LCOV
London Company of Virginia Portfolio holdings
AUM
$16.2B
1-Year Est. Return
17.5%
This Fund
S&P 500
This Quarter
Est. Return
+4.05%
1 Year Est. Return
+17.5%
3 Year Est. Return
+53.53%
5 Year Est. Return
+68.8%
10 Year Est. Return
+271.54%
AUM
$12.2B
AUM Growth
+$639M
(+5.5%)
Cap. Flow
+$259M
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
137
New
4
Increased
57
Reduced
54
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$141M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$116M |
| 3 |
General Mills
GIS
|
+$98.4M |
| 4 |
GE Aerospace
GE
|
+$93.5M |
| 5 |
Progressive
PGR
|
+$69.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$151M |
| 2 |
ConocoPhillips
COP
|
+$117M |
| 3 |
WDR
Waddell & Reed Financial, Inc.
WDR
|
+$72.9M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$65.7M |
| 5 |
EMC
EMC CORPORATION
EMC
|
+$58.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 20.6% |
| 2 | Consumer Discretionary | 16.01% |
| 3 | Financials | 14.03% |
| 4 | Consumer Staples | 12.73% |
| 5 | Technology | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cintas
CTAS
$81.4B
| $43.6M | 0.36% |
1,939,864
-91,308
| -4% | -$1.96M |
|
77
Amphenol
APH
$210B
| $39.8M | 0.33% |
2,751,568
-124,624
| -4% | -$1.62M |
|
|
ADT
78
DELISTED
ADT Corp
ADT
| $38.4M | 0.31% |
931,186
-883,882
| -49% | -$31M |
|
79
Tredegar Corp
TG
$281M
| $36.8M | 0.3% |
2,341,543
+64,680
| +3% | +$879K |
|
80
Pultegroup
PHM
$24.6B
| $35.1M | 0.29% |
1,876,991
-221,580
| -11% | -$3.78M |
|
81
Tejon Ranch
TRC
$441M
| $33.2M | 0.27% |
1,662,827
-4,463
| -0.3% | -$82.1K |
|
82
Vulcan Materials
VMC
$36.3B
| $32.7M | 0.27% |
309,816
-14,096
| -4% | -$1.34M |
|
83
Whirlpool
WHR
$2.79B
| $31.1M | 0.26% |
172,682
-6,671
| -4% | -$994K |
|
84
Brown-Forman Class B
BF.B
$12.8B
| $28.6M | 0.23% |
906,791
-41,159
| -4% | -$1.27M |
|
85
Albemarle
ALB
$15.1B
| $27.5M | 0.23% |
429,853
-17,346
| -4% | -$952K |
|
86
Dover
DOV
$28B
| $25.1M | 0.21% |
483,778
-22,144
| -4% | -$1.07M |
|
|
EMC
87
DELISTED
EMC CORPORATION
EMC
| $23.3M | 0.19% |
874,400
-2,306,845
| -73% | -$58.4M |
|
88
NetApp
NTAP
$39.6B
| $22.8M | 0.19% |
836,982
-28,612
| -3% | -$693K |
|
89
Ball Corp
BALL
$16.4B
| $22.5M | 0.18% |
631,484
-27,880
| -4% | -$950K |
|
90
Gen Digital
GEN
$17.1B
| $21.8M | 0.18% |
1,187,494
-47,131
| -4% | -$907K |
|
91
Voya Financial
VOYA
$9.01B
| $19.2M | 0.16% |
645,375
-24,167
| -4% | -$731K |
|
92
Corning
GLW
$144B
| $10.5M | 0.09% |
503,458
+412,748
| +455% | +$7.65M |
|
93
Philip Morris
PM
$290B
| $4.67M | 0.04% |
47,547
-145
| -0.3% | -$13.3K |
|
94
Mondelez International
MDLZ
$79.4B
| $1.86M | 0.02% |
46,311
+575
| +1% | +$23.4K |
|
95
ExxonMobil
XOM
$657B
| $1.54M | 0.01% |
18,404
-843
| -4% | -$67.5K |
|
96
CSX Corp
CSX
$92.8B
| $1.33M | 0.01% |
154,725
-7,800
| -5% | -$63.3K |
|
97
Smith & Wesson
SWBI
$636M
| $1.26M | 0.01% |
61,824
-12,359
| -17% | -$230K |
|
98
Johnson & Johnson
JNJ
$629B
| $1.14M | 0.01% |
10,492
-3,102
| -23% | -$321K |
|
99
Hershey
HSY
$37B
| $893K | 0.01% |
9,699
| – | – |
|
|
RTN
100
DELISTED
Raytheon Company
RTN
| $800K | 0.01% |
6,520
-712
| -10% | -$87.7K |
|
Similar funds
UCFA
IG
EIP
MG
CLGM
LCIP
EF
London Company of Virginia's Q1 2016 Portfolio in Review
As of Q1 2016, London Company of Virginia held 137 positions worth $12.2B, up 5.5% from $11.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
London Company of Virginia's Q1 2016 filing shows 4 new, 57 increased, 54 reduced and 17 closed positions. Its largest new stake was General Mills: 1,692,693 shares worth $107M. The largest sale was Bristol-Myers Squibb, an estimated $151M.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- London Company of Virginia's largest Q1 2016 buy was General Mills: 1,692,693 shares worth $107M.
- London Company of Virginia added most to Merck in Q1 2016, an estimated $141M increase.
- London Company of Virginia's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $151M.
- London Company of Virginia fully exited ConocoPhillips in Q1 2016, selling an estimated $117M.
- London Company of Virginia's ten largest holdings make up 27% of its $12.2B portfolio in Q1 2016.
- London Company of Virginia opened 4 new positions and closed 17 in Q1 2016.
- London Company of Virginia's portfolio value rose 5.5% quarter-over-quarter to $12.2B.
Based on London Company of Virginia's 13F filing for Q1 2016, filed 13 May 2016.